Search

Search Constraints

You searched for: Author/Creator Xu, Y

Search Results

9. 1229PReal world incidence, severity and timing of adverse events (AEs) among patients with metastatic non-small cell lung cancer (NSCLC) receiving second-line (2L) immuno-oncology (IO) therapy vs chemotherapy (C). (23rd October 2018)